Position in ABBV
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$3,645,256
+$327,230 QoQ
Shares Held
14,486
-5.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.61%
of 13F equity value
Holder Rank
#1,518
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VeraBank, N.A. holds $15,922,408 across 9 Drug Manufacturers - General names. ABBV ranks #2 (22.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
14,786 | $3,755,200 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
14,486 | $3,645,256 | |
| 3 | LLY |
ELI LILLY & Co
|
2,632 | $3,156,900 | |
| 4 | AMGN |
Amgen Inc
|
4,636 | $1,678,788 | |
| 5 | MRK |
Merck & Co., Inc.
|
10,222 | $1,313,526 | |
| 6 | GSK |
GSK plc
|
20,501 | $1,074,662 | |
| 7 | PFE |
Pfizer Inc
|
28,634 | $689,506 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,797 | $353,372 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,645,256 | 14,486 | Shares | Other | 2026-08-06 | |
| 2026-03-31 | $3,318,026 | 15,256 | Shares | Other | 2026-05-12 | |
| 2025-12-31 | $3,543,879 | 15,510 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $3,604,151 | 15,566 | Shares | Other | 2025-11-07 | |
| 2025-06-30 | $2,913,676 | 15,697 | Shares | Other | 2025-08-08 | |
| 2025-03-31 | $2,698,198 | 12,878 | Shares | Other | 2025-05-09 | |
| 2024-12-31 | $2,297,304 | 12,928 | Shares | Other | 2025-01-30 | |
| 2024-09-30 | $2,553,020 | 12,928 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $2,219,982 | 12,943 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $2,356,920 | 12,943 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $2,030,415 | 13,102 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,911,396 | 12,823 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $1,690,591 | 12,548 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $2,129,342 | 13,361 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $2,165,735 | 13,401 | Shares | Sole | 2023-01-25 | |
| 2022-09-30 | $1,792,374 | 13,355 | Shares | Sole | 2022-10-06 | |
| 2022-06-30 | $2,070,569 | 13,519 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $2,009,191 | 12,394 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $1,748,690 | 12,915 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $1,377,606 | 12,771 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $1,409,238 | 12,511 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $1,341,062 | 12,392 | Shares | Sole | 2021-04-13 | |
| 2020-12-31 | $1,327,802 | 12,392 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $1,085,414 | 12,392 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $1,216,646 | 12,392 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $944,146 | 12,392 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||